DocuSign, Inc. provides electronic signature software in the United States and internationally. The company provides e-signature solution that enables businesses to digitally prepare, sign, act on, and manage agreements. It also offers CLM, which automates workflows across the entire agreement process; Insights that use artificial intelligence (AI) to search and analyze agreements by legal concepts and clauses; Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce; Negotiate for Salesforce that supports for approvals, document comparisons, and version control; Analyzer, which helps customers understand what they're signing before they sign it; and CLM+ that provide AI-driven contract lifecycle management. The company provides Guided Forms, which enable complex forms to be filled via an interactive and step-by-step process; Click that supports no-signature-required agreements for standard terms and consents; Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; Payments that enables customers to collect signatures and payment; Remote Online Notary is a solution using audio-visual and identify verification technologies to enable notarization; and Monitor using advanced analytics to track DocuSign eSignature web, mobile, and API account. It offers industry-specific cloud offerings, including Rooms for Real Estate that provides a way for brokers and agents to manage the entire real estate transaction digitally; Rooms for Mortgage, which offers digital workspace to create and close mortgages; FedRAMP, an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise, commercial, and small businesses. The company was incorporated in 2003 and is headquartered in San Francisco, California.
DocuSign Stock Up 2.8 %
DocuSign stock opened at $74.34 on Friday. The firm's 50 day moving average price is $66.50 and its two-hundred day moving average price is $86.75. The firm has a market cap of $14.86 billion, a PE ratio of -165.20 and a beta of 1.21. DocuSign has a twelve month low of $55.86 and a twelve month high of $314.70. The company has a debt-to-equity ratio of 2.06, a quick ratio of 1.01 and a current ratio of 1.01.
DocuSign (NASDAQ:DOCU - Get Rating) last announced its quarterly earnings data on Thursday, June 9th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.04). DocuSign had a negative return on equity of 17.17% and a negative net margin of 4.00%. The firm had revenue of $588.69 million for the quarter, compared to analysts' expectations of $581.85 million. During the same quarter in the prior year, the business posted ($0.03) earnings per share. DocuSign's revenue was up 25.5% on a year-over-year basis. On average, research analysts predict that DocuSign will post -0.48 EPS for the current fiscal year.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on the stock. Royal Bank of Canada reduced their price objective on shares of DocuSign from $85.00 to $80.00 in a report on Friday, June 10th. JMP Securities dropped their price target on DocuSign from $180.00 to $151.00 and set a "market outperform" rating on the stock in a report on Friday, June 10th. Wedbush lowered DocuSign from a "neutral" rating to an "underperform" rating and reduced their price objective for the stock from $80.00 to $60.00 in a research note on Tuesday, May 3rd. Citigroup cut their target price on DocuSign from $114.00 to $90.00 and set a "buy" rating on the stock in a research report on Friday, June 10th. Finally, Wolfe Research cut DocuSign from a "market perform" rating to an "underperform" rating and set a $50.00 price target on the stock. in a research note on Monday, June 13th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $131.20.